Mayo Clinic Cancer Center (MCCC) is dedicated to understanding
the biology of cancer; discovering new ways to predict, prevent, diagnose
and treat cancer; and transforming the quality of life for cancer patients
today and in the future. MCCC has held the National Cancer Institute
(NCI) designation since the inception of the NCI Cancer Centers Program
more than 30 years ago. More than 350 M.D. and Ph.D. researchers are
members of MCCC. Cancer research is conducted in 12 major programs – Cancer
Imaging, Cancer Prevention and Control, Cell Biology, Developmental Therapeutics,
Gastrointestinal Cancer, Gene Therapy, Genetic Epidemiology and Risk
Assessment, Hematologic Malignancies, Immunology and Immunotherapy, Neuro-oncology,
Prostate Cancer and Women’s Cancers. The Cancer Center supports
18 Shared Resources. MCCC receives NCI’s Specialized Program of
Research Excellence (SPORE) funding for research in brain, breast, pancreatic
and prostate cancers as well as lymphoma and myeloma.
Mayo Clinic Cancer Center is a leader in translating knowledge
gained from cancer research into effective improvements in patient care.
MCCC treats more than 16,000 new cancer patients every year, making it
one of the largest cancer centers in the nation. Our three locations
in Arizona, Florida and Minnesota give MCCC a national reach to serve
diverse patient populations. Mayo Clinic’s research archive of
tissue samples and correlating medical records representing more than
five million patients is an invaluable resource for conducting cancer
research and one that no other institution in the world can match. In
addition to research and clinical care, MCCC has one of the largest and
most comprehensive cancer-focused patient education resource centers
in the country. The Mayo Clinic Cancer Education Center serves more than
40,000 people annually.
|
